Several oncogenic signaling pathways have been implicated in the progression of cartilaginous tumors, such as those related to cell migration (IMP3) and cell cycle (CDK4, MDM2, and β-catenin), which should be better elucidated. The gene discussed is IMP3; the disease is chondrogenic neoplasm.